Excaliard Pharmaceuticals, Inc.;Ionis Pharmaceuticals, Inc.
发明人:
申请号：
EP16150258.8
公开号：
EP3081648A1
申请日:
2009.08.25
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
This invention provides compounds which comprise modified oligonucleotides capable of inhibitory expression of connective tissue factor and composition containing same as well as methods of treating hyperprolific disorders and fibrotic diseases, and of reducing scarring resulting from wound healing using such compounds.
